Jan 16, 2020 / 07:30PM GMT
Federica Lussana;JPMorgan;Investment Banking Associate -
Good morning, everyone. My name is Federica Lussana. I'm part of the health care investment banking team of JPMorgan. I'm glad to introduce you to our next presenting company Revance Therapeutics. And our next speaker is going to be Mark Foley, Chief Executive Officer. Just as a kind reminder, there is going to be a breakout session in this room after the presentation. Thank you.
Mark J. Foley - Revance Therapeutics, Inc. - President, CEO & Director
Welcome, everyone. It's my pleasure to give you an overview of the company's 2020 plans and some of the key milestones that we'll be going after this year. Before I get started, I want to put up our forward-looking statement. So Revance is a Silicon Valley biotechnology company that's developed a very innovative, long-acting neuromodulator for use in both aesthetic and therapeutic applications. We're just down the street in Newark, California. And we do both of our drug substance and drug product manufacturing in our facility.
Revance Therapeutics Inc at JPMorgan Healthcare Conference Transcript
Jan 17, 2020
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers